SPL 1.04% 9.7¢ starpharma holdings limited

Ann: Starpharma commences phase 1/2 DEP irinotecan trial, page-22

  1. 3,347 Posts.
    lightbulb Created with Sketch. 792
    Unfortunately for us shareholders Stockrock, it is highly relevant that you have pointed out that the Phase2 trial recruitment has been painfully slow. It will unlikely be fully recruited by the end of 2019 CY at the rate they are going...
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.001(1.04%)
Mkt cap ! $40.00M
Open High Low Value Volume
9.7¢ 9.7¢ 9.5¢ $2.256K 23.47K

Buyers (Bids)

No. Vol. Price($)
1 231660 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 59887 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.